Answers are grounded in this paper and cite their sources.
The community-acquired MRSA USA 300 clone was the predominant cause of community-onset S. aureus skin and soft-tissue infection. Empirical use of agents active against community-acquired MRSA is warranted for patients presenting with serious skin and soft-tissue infections.
No takes yet. Share an insight, caveat, or question.
King et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: